presentation

A new allergic rhinitis therapy (MP29-02) is more effective than current first line monotherapies in providing allergic rhinitis patients relief from their nasal and ocular symptoms (rTNSS, rT5SS, rT7SS)

G Canonica, J Bousquet, J Mullol, JC Virchow, U Munzel and 1 more Published in 2013

Reference details